NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
21/05/2026
Voltar para busca
Dado oficial do USPTO
HVIVO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
22/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
12/06/2014
Data de registro
08/09/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/05/2026
Última transação
22/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
LEE, DOUGLAS
Localização atual
Historical data usage
Titulares e representantes
Titulares
HVIVO SERVICES LIMITED
HVIVO SERVICES LIMITED
Retroscreen Virology Limited
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemisation and compilation of medical information into computer databases; providing statistical information for business purposes, all of said information relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; services consisting of the registration, collection, transcription, compilation and systemization of written communications and data with respect to diagnostic testing; product demonstration services in the field of diagnostic testing; computerized database management services in the fields of diagnostic testing and preparations for the treatment, monitoring and diagnosis of disease; trade information services in the fields of medical, health, and clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance and billing records; providing business information for the purpose of providing referral services in the fields of medical, health and clinical care; providing business information regarding the results from medical and pharmaceutical diagnostic testing; providing business information regarding medical and pharmaceutical testing procedures; providing business information regarding disease conditions and disease prevention; providing business information regarding medical, hospital, insurance and billing records
Classe 42
Medical research services; scientific research in the nature of conducting clinical trials; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific research; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical research services, namely, clinical testing services for medical research purposes, pharmaceutical product evaluation to assist pharmacists for medical research purposes, and medical laboratory and testing services for medical research purposes; medical research into the causes and treatment of influenza and the common cold
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
21/05/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/05/2026
ES71
TEAS SECTION 71 RECEIVED
26/01/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/09/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/07/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
25/06/2022
71AG
REGISTERED-SEC.71 ACCEPTED
25/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/05/2022
ES71
TEAS SECTION 71 RECEIVED
11/11/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/09/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/05/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/03/2016
FIMP
FINAL DISPOSITION PROCESSED
28/03/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/12/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
24/07/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/06/2015
PUBO
PUBLISHED FOR OPPOSITION
23/06/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/05/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/04/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/04/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/04/2015
GNFR
FINAL REFUSAL E-MAILED
21/04/2015
CNFR
FINAL REFUSAL WRITTEN
21/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/04/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/04/2015
ALIE
ASSIGNED TO LIE
15/04/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/04/2015
RFNT
REFUSAL PROCESSED BY IB
23/01/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/01/2015
RFRR
REFUSAL PROCESSED BY MPU
08/01/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/01/2015
CNRT
NON-FINAL ACTION WRITTEN
05/01/2015
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2015
DOCK
ASSIGNED TO EXAMINER
30/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/12/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HVIVO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.